Literature DB >> 22047388

Accuracy of Acuros XB and AAA dose calculation for small fields with reference to RapidArc(®) stereotactic treatments.

Antonella Fogliata1, Giorgia Nicolini, Alessandro Clivio, Eugenio Vanetti, Luca Cozzi.   

Abstract

PURPOSE: To assess the accuracy against measurements of two photon dose calculation algorithms (Acuros XB and the Anisotropic Analytical algorithm AAA) for small fields usable in stereotactic treatments with particular focus on RapidArc(®).
METHODS: Acuros XB and AAA were configured for stereotactic use. Baseline accuracy was assessed on small jaw-collimated open fields for different values for the spot sizes parameter in the beam data: 0.0, 0.5, 1, and 2 mm. Data were calculated with a grid of 1 × 1 mm(2). Investigated fields were: 3 × 3, 2 × 2, 1 × 1, and 0.8 × 0.8 cm(2) with a 6 MV photon beam generated from a Clinac2100iX (Varian, Palo Alto, CA). Profiles, PDD, and output factors were measured in water with a PTW diamond detector (detector size: 4 mm(2), thickness 0.4 mm) and compared to calculations. Four RapidArc test plans were optimized, calculated and delivered with jaw settings J3 × 3, J2 × 2, and J1 × 1 cm(2), the last was optimized twice to generate high (H) and low (L) modulation patterns. Each plan consisted of one partial arc (gantry 110° to 250°), and collimator 45°. Dose to isocenter was measured in a PTW Octavius phantom and compared to calculations. 2D measurements were performed by means of portal dosimetry with the GLAaS method developed at authors' institute. Analysis was performed with gamma pass-fail test with 3% dose difference and 2 mm distance to agreement thresholds.
RESULTS: Open square fields: penumbrae from open field profiles were in good agreement with diamond measurements for 1 mm spot size setting for Acuros XB, and between 0.5 and 1 mm for AAA. Maximum MU difference between calculations and measurements was 1.7% for Acuros XB (0.2% for fields greater than 1 × 1 cm(2)) with 0.5 or 1 mm spot size. Agreement for AAA was within 0.7% (2.8%) for 0.5 (1 mm) spot size. RapidArc plans: doses were evaluated in a 4 mm diameter structure at isocenter and computed values differed from measurements by 0.0, -0.2, 5.5, and -3.4% for Acuros XB calculations (1 mm spot size), and of -0.1, 0.3, 6.7, and -1.2% for AAA, respectively for J3 × 3, J2 × 2, J1 × 1H, J1 × 1L RapidArc plans. Gamma Agreement Index from 2D dose analysis was higher than 95% for J3 × 3 and J2 × 2 plans, being around 80% for J1 × 1 maps. Sensitivity with respect to the dosimetric leaf gap and transmission factor MLC parameters was evaluated in the four RapidArc plans, showing the need to properly set the dosimetric leaf gap for accurate calculations.
CONCLUSIONS: Acuros XB and AAA showed acceptable characteristics for stereotactic small fields if adequate tuning of configuration parameters is performed. Dose calculated for RapidArc stereotactic plans showed an acceptable agreement against point and 2D measurements. Both algorithms can therefore be considered safely applicable to stereotactic treatments.

Entities:  

Mesh:

Year:  2011        PMID: 22047388     DOI: 10.1118/1.3654739

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  14 in total

1.  Utility and validation of biomechanical deformable image registration in low-contrast images.

Authors:  Michael Velec; Titania Juang; Joanne L Moseley; Mark Oldham; Kristy K Brock
Journal:  Pract Radiat Oncol       Date:  2015-03-29

2.  Reference dataset of users' photon beam modeling parameters for the Eclipse, Pinnacle, and RayStation treatment planning systems.

Authors:  Mallory C Glenn; Christine B Peterson; David S Followill; Rebecca M Howell; Julianne M Pollard-Larkin; Stephen F Kry
Journal:  Med Phys       Date:  2019-11-15       Impact factor: 4.071

3.  A depth dose study between AAA and AXB algorithm against Monte Carlo simulation using AIP CT of a 4D dataset from a moving phantom.

Authors:  Roger Cai Xiang Soh; Guan Heng Tay; Wen Siang Lew; James Cheow Lei Lee
Journal:  Rep Pract Oncol Radiother       Date:  2018-09-03

4.  Dosimetric accuracy and clinical quality of Acuros XB and AAA dose calculation algorithm for stereotactic and conventional lung volumetric modulated arc therapy plans.

Authors:  Petra S Kroon; Sandra Hol; Marion Essers
Journal:  Radiat Oncol       Date:  2013-06-24       Impact factor: 3.481

5.  The effect of body contouring on the dose distribution delivered with volumetric-modulated arc therapy technique.

Authors:  Jaegi Lee; Jong Min Park; Hong-Gyun Wu; Jin Ho Kim; Sung-Joon Ye
Journal:  J Appl Clin Med Phys       Date:  2015-11-08       Impact factor: 2.102

6.  Tuning of AcurosXB source size setting for small intracranial targets.

Authors:  Stephen J Gardner; Siming Lu; Chang Liu; Ning Wen; Indrin J Chetty
Journal:  J Appl Clin Med Phys       Date:  2017-05-04       Impact factor: 2.102

7.  Dosimetric effects of immobilization devices on SABR for lung cancer using VMAT technique.

Authors:  Jong In Park; Sung-Joon Ye; Hak Jae Kim; Jong Min Park
Journal:  J Appl Clin Med Phys       Date:  2015-01-08       Impact factor: 2.102

8.  Critical appraisal of RapidArc radiosurgery with flattening filter free photon beams for benign brain lesions in comparison to GammaKnife: a treatment planning study.

Authors:  Ufuk Abacioglu; Zeynep Ozen; Meltem Yilmaz; Alptekin Arifoglu; Basri Gunhan; Namik Kayalilar; Selcuk Peker; Meric Sengoz; Salih Gurdalli; Luca Cozzi
Journal:  Radiat Oncol       Date:  2014-05-21       Impact factor: 3.481

9.  On the robustness of VMAT-SABR treatment plans against isocentre positioning uncertainties.

Authors:  Joep Stroom; Sandra Vieira; Dalila Mateus; Carlo Greco; Antonella Fogliata; Giorgia Nicolini; Alessandro Clivio; Eugenio Vanetti; Luca Cozzi
Journal:  Radiat Oncol       Date:  2014-09-05       Impact factor: 3.481

10.  Difference in dose-volumetric data between the analytical anisotropic algorithm, the dose-to-medium, and the dose-to-water reporting modes of the Acuros XB for lung stereotactic body radiation therapy.

Authors:  Wambaka A Mampuya; Mitsuhiro Nakamura; Yoshinori Hirose; Kenji Kitsuda; Takashi Ishigaki; Takashi Mizowaki; Masahiro Hiraoka
Journal:  J Appl Clin Med Phys       Date:  2016-09-08       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.